IP Library Granted Patent US 7,842,479
Granted Patent B2
US 7,842,479 · App. 11/597,013 · Granted Nov 30, 2010

Methods for altering acetic acid production and enhancing cell death in bacteria

Assignee: The Board of Regents of the University of Nebraska
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,842,479
App. No.
11/597,013
Granted
Nov 30, 2010
Kind
B2
Abstract

Methods of increasing cultured cell growth yields and/or protein production from bacterial cell cultures are provided. More particularly, mutant bacterial cells having an alteration in the expression or activity of the cidABC operon, a gene therein, or a homolog or a regulator thereof, and methods for reducing acetic acid/acetate production in cultures are provided, as are methods for increasing cultured cell growth yields and/or protein production employing such cells. Methods for enhancing bacterial cell death and methods for identifying agents that increase the susceptibility of bacteria to cell death are also provided.

Claims (24)

1. An isolated bacterial cell comprising an inactivating mutation in a Staphylococcus aureus cidC gene encoding the amino acid sequence set forth as SEQ ID NO: 2, which mutation measurably reduces acetate production by the cell when the cell is grown in medium comprising a metabolizable carbon source.

2. The isolated bacterial cell of claim 1 , wherein the mutation measurably reduces acetate production by the cell, in comparison to an isogenic cell not comprising the mutation, when grown in medium comprising glucose.

3. The isolated bacterial cell of claim 1 , wherein the mutation in a cidC gene is a knockout mutation.

4. A method for producing a polypeptide, comprising:

culturing the isolated bacterial cell of claim 1 , and

isolating the polypeptide from the culture medium;

wherein the mutant bacterial cell further comprises a nucleic acid encoding the polypeptide.

5. A method for increasing yield in a bacterial cell culture, wherein increased yield is measured as an increase in bacterial biomass, an increase in production of a product, an increase in turbidity, an increase in optical density, or a combination of two or more thereof, comprising culturing the isolated bacterial cell of claim 1 , wherein the mutation measurably reduces acetate production by the bacterial cell in comparison to an isogenic cell not having the mutation, and wherein the reduced acetate production results in increased yield.

6. An isolated bacterial cell comprising an inactivating mutation in a gene encoding a Staphylococcus pyruvate oxidase polypeptide, wherein the pyruvate oxidase has at least 95% sequence identity with the amino acid sequence set forth as SEQ ID NO: 2, which inactivating mutation measurably reduces acetate production by the cell when the cell is grown in culture medium comprising a metabolizable carbon source.

7. The isolated bacterial cell of claim 6 , wherein the mutation measurably reduces acetate production by the cell, in comparison to an isogenic cell not comprising the inactivating mutation, when grown in medium comprising glucose.

8. The isolated bacterial cell of claim 6 , wherein the inactivating mutation is a knockout mutation.

9. A method for producing a polypeptide, comprising:

cultivating the isolated bacterial cell of claim 6 in a culture medium; and

isolating the polypeptide from the culture medium;

wherein the isolated bacterial cell further comprises a nucleic acid encoding the polypeptide.

10. A method for increasing yield in a bacterial cell culture, wherein increased yield is measured as an increase in bacterial biomass, an increase in production of a product, an increase in turbidity, an increase in optical density, or a combination of two or more thereof, the method comprising culturing the isolated bacterial cell of claim 6 ; wherein the inactivating mutation measurably reduces acetate production by the bacterial cell in comparison to an isogenic cell not having the inactivating mutation, and wherein the reduced acetate production results in increased yield.

11. An isolated bacterial cell comprising an inactivating mutation in a gene encoding a Staphylococcus pyruvate oxidase polypeptide, wherein the pyruvate oxidase has at least 98% sequence identity with the amino acid sequence set forth as SEQ ID NO: 2, which inactivating mutation measurably reduces acetate production by the cell when the cell is grown in culture medium comprising a metabolizable carbon source.

12. The isolated bacterial cell of claim 11 , wherein the inactivating mutation measurably reduces acetate production by the cell, in comparison to an isogenic cell not comprising the inactivating mutation, when grown in medium comprising glucose.

13. The isolated bacterial cell of claim 11 , wherein the inactivating mutation is a knockout mutation.

14. A method for producing a polypeptide, comprising:

cultivating the isolated bacterial cell of claim 11 in a culture medium; and

isolating the polypeptide from the culture medium,

wherein the isolated bacterial cell further comprises a nucleic acid encoding the polypeptide.

15. A method for increasing yield in a bacterial cell culture, wherein increased yield is measured as an increase in bacterial biomass, an increase in production of a product, an increase in turbidity, an increase in optical density, or a combination of two or more thereof, the method comprising culturing the isolated bacterial cell of claim 11 ; wherein the inactivating mutation measurably reduces acetate production by the bacterial cell in comparison to an isogenic cell not having the inactivating mutation, and wherein the reduced acetate production results in increased yield.

Assignments (4)
CONFIRMATORY LICENSE Recorded Feb 10, 2015
From: UNIVERSITY OF NEBRASKA MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034926/0839 →
CONFIRMATORY LICENSE Recorded Oct 7, 2011
From: UNIVERSITY OF NEBRASKA MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027029/0423 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2010
From: UNIVERSITY OF IDAHO
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Reel/Frame 024856/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2010
From: IDAHO RESEARCH FOUNDATION, INC.
To: UNIVERSITY OF IDAHO
Reel/Frame 024848/0443 →
Continuity (3)
Provisional Application 6057343100 · May 21, 2004
Provisional Application 6064203900 · Jan 6, 2005
Related Publication 20070231841A1 · Oct 4, 2007